PATENT CLAIM ANALYSIS

Application Number: 16172960
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-02
Patent Classification: ["424", "197110"]

Abstract:
The present invention describes a combined vaccine that offers broad protection against meningococcal disease caused by the pathogenic bacteria  Neisseria meningitidis.  The vaccine is comprised of four distinct polysaccharide-protein conjugates that are formulated as a single dose of vaccine. Purified capsular polysaccharides from  Neisseria meningitidis  serogroups A, C, W-135, and Y are chemically activated and selectively attached to a carrier protein by means of a covalent chemical bond, forming polysaccharide-protein conjugates capable of eliciting long-lasting immunity to a variety of  N. meningitidis  strains in children as well as adults.

Claim (Index 26):
The method of  claim 18 , wherein said carrier protein species is CRM 197 .

Metadata:
- Claim Count in Document: 41.0
- Percentile: 97.0
- Lexical Diversity: 1.41176
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14636870', '13843037', '10054638', '14257551', '13738698']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7940698640107631
- 35 USC 102 Novelty (BERT): 0.6057990946577705
- Combined Prediction Score: 0.7752427870754639
- Mean Citation Score: 582.529948
- Max Citation Score: 583.8678
- Similarity Product: 447.1049756511569

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test